Estimaciones de analistas de Wall Street para The Clorox Company (CLX): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Ratios de valoración
| Ratio P/E | 17.49 |
| Precio / Valor contable | 114.04 |
| EV / EBITDA | 17.28 |
| Rentabilidad por dividendo | 5.90% |
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $5.97B | $6.12B | $6.21B | $6.72B | $7.34B | $7.11B | $7.39B | $7.09B | $7.10B | $6.72B |
| Coste de Ventas | $3.30B | $3.45B | $3.49B | $3.66B | $4.14B | $4.56B | $4.48B | $4.04B | $3.89B | $3.88B |
| Beneficio Bruto | $2.67B | $2.67B | $2.73B | $3.06B | $3.20B | $2.54B | $2.91B | $3.05B | $3.21B | $2.84B |
| I+D | $135.0M | $132.0M | $136.0M | $145.0M | $149.0M | $132.0M | $138.0M | $126.0M | $121.0M | $116.0M |
| Generales y Administrativos | $1.41B | $1.41B | $1.47B | $1.64B | $1.79B | $1.66B | $1.92B | $2.17B | $1.89B | $1.07B |
| Gastos Operativos | $1.55B | $1.55B | $1.62B | $1.80B | $1.97B | $1.83B | $2.08B | $2.33B | $2.04B | $1.18B |
| Beneficio Operativo | $1.12B | $1.12B | $1.11B | $1.26B | $1.23B | $719.0M | $823.0M | $723.0M | $1.18B | $1.66B |
| EBITDA | $1.28B | $1.30B | $1.30B | $1.46B | $1.21B | $937.0M | $564.0M | $723.0M | $1.39B | $921.0M |
| Gastos por Intereses | $88.0M | $85.0M | $97.0M | $99.0M | $99.0M | $106.0M | $90.0M | $90.0M | $88.0M | $130.0M |
| Beneficio Antes de Impuestos | $1.03B | $1.05B | $1.02B | $1.19B | $900.0M | $607.0M | $238.0M | $398.0M | $1.08B | $791.0M |
| Impuestos | $330.0M | $231.0M | $204.0M | $246.0M | $181.0M | $136.0M | $77.0M | $106.0M | $254.0M | $190.0M |
| Beneficio Neto | $701.0M | $823.0M | $820.0M | $939.0M | $710.0M | $462.0M | $149.0M | $280.0M | $810.0M | $587.0M |
| BPA | $5.43 | $6.37 | $6.42 | $7.46 | $5.65 | $3.75 | $1.21 | $2.25 | $6.56 | $4.82 |
| BPA Diluido | $5.33 | $6.25 | $6.32 | $7.35 | $5.58 | $3.73 | $1.20 | $2.25 | $6.52 | $4.81 |
| Acciones en Circulación (Diluidas) | $131.6M | $131.6M | $129.8M | $127.7M | $127.3M | $123.9M | $124.2M | $124.8M | $124.3M | $122.1M |
Precio
| Precio | $84.86 |
| Capitalización | $10.3B |
| Bolsa | NYSE |
| País | US |
Empresas relacionadas: BF-B · BJ · CHD · COKE · HRL · MKC · PFGC
Explorar sector: Consumer Defensive · Household & Personal Products
Más secciones de CLX: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones